Reference List

Reference List
Lupus Nephritis Update Search
Jan 1, 2013 to Sep 30, 2013
This update search is the result of the replicated search strategy used to identify studies for the
original evidence report that informed guideline development for Screening, Treatment, and
Management of Lupus Nephritis.
These results have not been screened to determine relevancy of studies. There may be some
overlap with the results of the original search, and some references outside the indicated time
frame. There may be other sources not searched that would yield relevant studies.
Please also see results from the end of original search to end of 4th quarter 2012 (Feb 1, 2012 to
Dec 31, 2012).
1. Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S. Up-regulation of transcription factor Blimp1
in systemic lupus erythematosus. Mol Immunol 2013;56:574-82. PMID: PM:23911415
2. Suwanichkul A, Wenderfer SE. Differential expression of functional Fc-receptors and
additional immune complex receptors on mouse kidney cells. Mol Immunol 2013;56:369-79.
PMID: PM:23911392
3. Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT. Complement factor H related
proteins (CFHRs). Mol Immunol 2013;56:170-80. PMID: PM:23830046
4. Zhu FG, Jiang W, Bhagat L, Wang D, Yu D, Tang JX ,et al. A novel antagonist of Toll-like
receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice.
Autoimmunity 2013;46:419-28. PMID: PM:24083389
5. Shinsuke N, Hiroshi I. Overexpression of Epstein-Barr virus-induced gene 3 protein (EBI3) in
MRL/lpr mice suppresses their lupus nephritis by activating regulatory T cells. Autoimmunity
2013;46:446-54. PMID: PM:23845089
6. Andrejevic S, Jeremic I, Sefik-Bukilica M, Nikolic M, Stojimirovic B, Bonaci-Nikolic B.
Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the
most closely associated with the disease activity. Clin Rheumatol 2013;32:1619-26. PMID:
PM:23857662
7. Chen YT, Wei CC, Ng KL, Chen CH, Chan CJ, Chen XX ,et al. Toll-like receptor 9 SNPs are
susceptible to the development and progression of membranous glomerulonephritis: 27 years
follow-up in Taiwan. Ren Fail 2013;35:1370-5. PMID: PM:23964786

8. Alharazy SM, Kong NC, Mohd M, Shah SA, Abdul Gafor AH, Ba IA. The role of urinary
neutrophil gelatinase-associated lipocalin in lupus nephritis. Clin Chim Acta 2013;425:163-8.
PMID: PM:23954775
9. Mathis KW, Venegas-Pont M, Flynn ER, Williams JM, Maric-Bilkan C, Dwyer TM ,et al.
Hypertension in an experimental model of systemic lupus erythematosus occurs independently of
the renal nerves. Am J Physiol Regul Integr Comp Physiol 2013;305:R711-R719. PMID:
PM:23926131
10. Bauer ME, Bateman BT, Bauer ST, Shanks AM, Mhyre JM. Maternal sepsis mortality and
morbidity during hospitalization for delivery: temporal trends and independent associations for
severe sepsis. Anesth Analg 2013;117:944-50. PMID: PM:24023020
11. Zhao W, Berthier CC, Lewis EE, McCune WJ, Kretzler M, Kaplan MJ. The peroxisomeproliferator activated receptor-gamma agonist pioglitazone modulates aberrant T cell responses
in systemic lupus erythematosus. Clin Immunol 2013;149:119-32. PMID: PM:23962407
12. Grenzi PC, de MR, Silva RZ, Campos EF, Gerbase-Delima M. Antibodies against denatured
HLA class II molecules detected in luminex-single antigen assay. Hum Immunol 2013;74:13003. PMID: PM:23831256
13. Ayodele OE, Okpechi IG, Swanepoel CR. Long-term renal outcome and complications in
South Africans with proliferative lupus nephritis. Int Urol Nephrol 2013;45:1289-300. PMID:
PM:23306862
14. Al-Shami A, Crisostomo J, Wilkins C, Xu N, Humphries J, Chang WC ,et al. Integrin-alpha
FG-GAP Repeat-Containing Protein 2 Is Critical for Normal B Cell Differentiation and Controls
Disease Development in a Lupus Model. J Immunol 2013;191:3789-98. PMID: PM:23997217
15. Jin T, Almehed K, Zhu Y, Carlsten H, Forsblad-d'Elia H. Soluble E-cadherin in Systemic
Lupus Erythematosus. J Rheumatol 2013;40:1677-82. PMID: PM:23996289
16. Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN.
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired
Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood
Cancer 2013;60:1676-82. PMID: PM:23729372
17. Olsen NJ, Yousif M, Mutwally A, Cory M, Elmagboul N, Karp DR. Organ damage in highrisk patients with systemic and incomplete lupus syndromes. Rheumatol Int 2013;33:2585-90.
PMID: PM:23715694
18. Chen Y, Cameron A. Aspergillosis after liver transplantation in the context of common
variable immunodeficiency: case report. Transpl Infect Dis 2013;15:540-4. PMID:
PM:23676145

19. Lim LM, Chang JM, Wang IF, Chang WC, Hwang DY, Chen HC. Atypical X-linked
agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M
deficiency patient. BMC Pediatr 2013;13:150. PMID: PM:24074005
20. Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M ,et al. Targeting interleukin-6 in
inflammatory autoimmune diseases and cancers. Pharmacol Ther 2013; PMID: PM:24076269
21. Kalkan G, Karakus N, Bas Y, Takci Z, Ozuguz P, Ates O ,et al. The association between
Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish
population. Gene 2013;527:565-9. PMID: PM:23831512
22. Rankin AL, Seth N, Keegan S, Andreyeva T, Cook TA, Edmonds J ,et al. Selective
Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis. J
Immunol 2013; PMID: PM:24068666
23. Freeley SJ, Giorgini A, Tulone C, Popat RJ, Horsfield C, Robson MG. Toll-Like Receptor 2
or Toll-Like Receptor 4 Deficiency Does Not Modify Lupus in MRLlpr Mice. PLoS One
2013;8:e74112. PMID: PM:24086313
24. Emerah AA, El-Shal AS. Role of vitamin D receptor gene polymorphisms and serum 25hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus. Mol
Biol Rep 2013; PMID: PM:24057183
25. Talaei N, Cheung YH, Landolt-Marticorena C, Noamani B, Li T, Wither JE. T Cell and
Dendritic Cell Abnormalities Synergize to Expand Pro-Inflammatory T Cell Subsets Leading to
Fatal Autoimmunity in B6.NZBc1 Lupus-Prone Mice. PLoS One 2013;8:e75166. PMID:
PM:24073245
26. Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA. Overall and cause-specific
mortality in patients with systemic lupus erythematosus: A meta-analysis of observational
studies. Arthritis Care Res (Hoboken ) 2013; PMID: PM:24106157
27. McGrew AK, Ballweber LR, Moses SK, Stricker CA, Beckmen KB, Salman MD ,et al.
Mercury in gray wolves (Canis lupus) in Alaska: Increased exposure through consumption of
marine prey. Sci Total Environ 2013;468-469C:609-13. PMID: PM:24056451
28. Lenihan CR, Tan JC, Kambham N. Acute transplant glomerulopathy with monocyte rich
infiltrate. Transpl Immunol 2013; PMID: PM:24056179
29. Fei Y, Shi X, Gan F, Li X, Zhang W, Li M ,et al. Death causes and pathogens analysis of
systemic lupus erythematosus during the past 26 years. Clin Rheumatol 2013; PMID:
PM:24046218
30. Lee J, Peschken C, Muangchan C, Silverman E, Pineau C, Smith C ,et al. The frequency of
and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus
Canadian cohort. Lupus 2013; PMID: PM:24048215

31. Kalkan G, Yigit S, Karakus N, Bas Y, Seckin HY. Association between interleukin 4 gene
intron 3 VNTR polymorphism and recurrent aphthous stomatitis in a cohort of Turkish patients.
Gene 2013;527:207-10. PMID: PM:23756192
32. Kim MK, Maeng YI, Lee SJ, Lee IH, Bae J, Kang YN ,et al. Pathogenesis and significance
of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways. Int J
Clin Exp Pathol 2013;6:2157-67. PMID: PM:24133594
33. Koscielska-Kasprzak K, Bartoszek D, Myszka M, Zabinska M, Klinger M. The Complement
Cascade and Renal Disease. Arch Immunol Ther Exp (Warsz ) 2013; PMID: PM:24030732
34. Apostolidis SA, Rauen T, Hedrich CM, Tsokos GC, Crispin JC. Protein Phosphatase 2A
Enables Expression of Interleukin 17 (IL-17) through Chromatin Remodeling. J Biol Chem
2013;288:26775-84. PMID: PM:23918926
35. Jiang T, Tian F, Zheng H, Whitman SA, Lin Y, Zhang Z ,et al. Nrf2 suppresses lupus
nephritis through inhibition of oxidative injury and the NF-kappaB-mediated inflammatory
response. Kidney Int 2013; PMID: PM:24025640
36. Zhao J, Wang H, Dai C, Wang H, Zhang H, Huang Y ,et al. P2X7 blockade attenuates lupus
nephritis by inhibiting NLRP3/ASC/caspase-1 activation. Arthritis Rheum 2013; PMID:
PM:24022661
37. Zhuang H, Han S, Xu Y, Li Y, Wang H, Yang LJ ,et al. Toll-like receptor 7-stimulated tumor
necrosis factor alpha causes bone marrow damage in systemic lupus erythematosus. Arthritis
Rheum 2013; PMID: PM:24022519
38. Joy MS, Frye RF, Nolin TD, Roberts BV, La MK, Wang J ,et al. In Vivo Alterations in Drug
Metabolism and Transport Pathways in Patients with Chronic Kidney Diseases.
Pharmacotherapy 2013; PMID: PM:24038489
39. Zhou L, Sun L, Wu H, Zhang L, Chen M, Liu J ,et al. Oridonin ameliorates lupus-like
symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF). Eur J
Pharmacol 2013;715:230-7. PMID: PM:23712004
40. Slae M, Heshin-Bekenstein M, Simckes A, Heimer G, Engelhard D, Eisenstein EM. Female
polysomy-X and systemic lupus erythematosus. Semin Arthritis Rheum 2013; PMID:
PM:24012046
41. Subramaniam SR, Cader RA, Mohd R, Yen KW, Ghafor HA. Low-dose cyclophosphamideinduced acute hepatotoxicity. Am J Case Rep 2013;14:345-9. PMID: PM:24023976
42. de Souza AW, Westra J, Bijzet J, Limburg PC, Stegeman CA, Bijl M ,et al. Is serum
HMGB1 a biomarker in ANCA-Associated vasculitis? Arthritis Res Ther 2013;15:R104. PMID:
PM:24007972

43. Ratkovic M, Basic-Jukic N, Gledovic B, Radunovic D. Thrombosis of the great cerebral vein
in a hemodialysis patient. Hemodial Int 2013; PMID: PM:23998712
44. Clowse ME, Wallace DJ, Weisman M, James A, Criscione-Schreiber LG, Pisetsky DS.
Predictors of preterm birth in patients with mild systemic lupus erythematosus. Ann Rheum Dis
2013;72:1536-9. PMID: PM:23361085
45. Haddiya I, Rhou H, Benamar L, Ezzaitouni F, Bayahia R, Ouzeddoun N. Idiopathic
membranous nephropathy preceding the onset of rheumatoid arthritis: a case report. Arab J
Nephrol Transplant 2013;6:181-3. PMID: PM:24053746
46. Al-Saegh RM, Assad LW. The spectrum of glomerular diseases as studied by
immunofluorescence microscopy a single center study in iraq. Arab J Nephrol Transplant
2013;6:161-7. PMID: PM:24053742
47. Mina-Osorio P, Lastant J, Keirstead N, Whittard T, Ayala J, Stefanova S ,et al. Suppression
of Glomerulonephritis in Lupus-Prone NZB x NZW Mice by RN486, a Selective Inhibitor of
Bruton's Tyrosine Kinase. Arthritis Rheum 2013;65:2380-91. PMID: PM:23754328
48. Mysler EF, Spindler AJ, Guzman R, Bijl M, Jayne D, Furie RA ,et al. Efficacy and Safety of
Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, DoubleBlind, Phase III Study. Arthritis Rheum 2013;65:2368-79. PMID: PM:23740801
49. Cartella S, Cavazzana I, Ceribelli A, Inverardi F, Tincani A, Franceschini F. Evaluation of
mortality, disease activity, treatment, clinical and immunological features of adult and late onset
systemic Lupus erythematosus. Autoimmunity 2013;46:363-8. PMID: PM:23706114
50. Wang YB, Wang Q, Yao YM, Sheng ZY, Liu YF. Effect of Xuebijing injection on systemic
lupus erythematosus in mice. Chin J Integr Med 2013;19:675-82. PMID: PM:23975132
51. Collins E, Gilkeson G. Hematopoetic and mesenchymal stem cell transplantation in the
treatment of refractory systemic lupus erythematosus--where are we now? Clin Immunol
2013;148:328-34. PMID: PM:23411031
52. Carugati M, Franzetti M, Torre A, Giorgi R, Genderini A, Strambio de CF ,et al. Systemic
lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and
review of the literature. Clin Rheumatol 2013;32:1399-405. PMID: PM:23649483
53. Telles RW, Lanna CC, Sousa AJ, Navarro TP, Souza FL, Rodrigues LA ,et al. Progression of
carotid atherosclerosis in patients with systemic lupus erythematosus. Clin Rheumatol
2013;32:1293-300. PMID: PM:23620348
54. Chen TK, Fine DM. Top 10 developments in lupus nephritis. Curr Rheumatol Rep
2013;15:358. PMID: PM:23893235

55. Danes I, Agusti A, Vallano A, Martinez J, Alerany C, Ferrer A ,et al. Available evidence and
outcome of off-label use of rituximab in clinical practice. Eur J Clin Pharmacol 2013;69:168999. PMID: PM:23700188
56. Kosmas C, Papachrysanthou T, Daladimos T, Athanasopoulos A, Tsavaris N,
Vlachoyiannopoulos PG. Control of relapsed germ cell tumor and SLE nephritis by high-dose
chemotherapy and autologous hematopoietic cell transplantation. Future Oncol 2013;9:1401-6.
PMID: PM:23980687
57. Xu Z, Croker BP, Morel L. The combination of two Sle2 lupus-susceptibility loci and
Cdkn2c deficiency leads to T-cell-mediated pathology in B6.Fas(lpr) mice. Genes Immun
2013;14:373-9. PMID: PM:23698709
58. Mackern-Oberti JP, Llanos C, Carreno LJ, Riquelme SA, Jacobelli SH, Anegon I ,et al.
Carbon monoxide exposure improves immune function in lupus-prone mice. Immunology
2013;140:123-32. PMID: PM:23691924
59. Zhao J, Zhang H, Huang Y, Wang H, Wang S, Zhao C ,et al. Bay11-7082 attenuates murine
lupus nephritis via inhibiting NLRP3 inflammasome and NF-kappaB activation. Int
Immunopharmacol 2013;17:116-22. PMID: PM:23770281
60. Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol 2013;24:135766. PMID: PM:23929771
61. Sevignani G, Soares MF, Marques GL, Freitas AK, Gentili A, Chula DC ,et al. Acute kidney
injury in patients infected by H1N1: clinical histological correlation in a series of cases. J Bras
Nefrol 2013;35:185-90. PMID: PM:24100737
62. Stojan G, Petri M. Atherosclerosis in systemic lupus erythematosus. J Cardiovasc Pharmacol
2013;62:255-62. PMID: PM:23792700
63. Morel N, Bachelot A, Chakhtoura Z, Ghillani-Dalbin P, Amoura Z, Galicier L ,et al. Study of
anti-Mullerian hormone and its relation to the subsequent probability of pregnancy in 112
patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. J Clin
Endocrinol Metab 2013;98:3785-92. PMID: PM:23833039
64. Gatla N, Annapureddy N, Sequeira W, Jolly M. Posterior reversible encephalopathy
syndrome in systemic lupus erythematosus. J Clin Rheumatol 2013;19:334-40. PMID:
PM:23965484
65. Nguyen HC, Dimou A, Govil A, Balasubramanian M, Jacobs-Kosmin D. Primary
antiphospholipid syndrome and necrotizing pancreatitis: a diagnostic challenge. J Clin
Rheumatol 2013;19:348-50. PMID: PM:23965475

66. Cleaver N, Ramirez J, Gildenberg S. Cutaneous lupus erythematosus in a patient undergoing

intravitreal bevacizumab injections: case report and review of the literature. J Drugs Dermatol
2013;12:1052-5. PMID: PM:24002156
67. Bossaller L, Rathinam VA, Bonegio R, Chiang PI, Busto P, Wespiser AR ,et al.
Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and
renal pathology in pristane-induced lupus. J Immunol 2013;191:2104-14. PMID: PM:23918976
68. Bert JS, Abdullah M, Dahle TG, Gertner E. Transcatheter aortic valve replacement for
advanced valvular disease in active SLE and APS. Lupus 2013;22:1046-9. PMID: PM:23884983
69. Williams AE, Crofts G, Teh LS. 'Focus on feet'--the effects of systemic lupus erythematosus:
a narrative review of the literature. Lupus 2013;22:1017-23. PMID: PM:23877874
70. Korbet SM, Lewis EJ. Severe lupus nephritis: the predictive value of a >=50% reduction in
proteinuria at 6 months. Nephrol Dial Transplant 2013;28:2313-8. PMID: PM:23787551
71. Hanouna G, Morel N, Le Thi HD, Josselin L, Vauthier-Brouzes D, Saadoun D ,et al.
Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases.
Rheumatology (Oxford) 2013;52:1635-41. PMID: PM:23676524
72. Hussein MM, Mooij JM, Al MN, Demerdash TM. Late response to rituximab in a dialysis
patient with severe lupus nephritis. Saudi J Kidney Dis Transpl 2013;24:976-80. PMID:
PM:24029264
73. Inda-Filho A, Neugarten J, Putterman C, Broder A. Improving outcomes in patients with
lupus and end-stage renal disease. Semin Dial 2013;26:590-6. PMID: PM:24004337
74. Lin YH, Lo LM, Hsieh CC, Chiu TH, Hsieh TT, Hung TH. Perinatal outcome in normal
pregnant women with incidental thrombocytopenia at delivery. Taiwan J Obstet Gynecol
2013;52:347-50. PMID: PM:24075371
75. Todeschini P, La MG, Dalmastri V, Feliciangeli G, Cuna V, Montanari M ,et al. Incidence of
late deep venous thrombosis among renal transplant patients. Transplant Proc 2013;45:2666-8.
PMID: PM:24034019
76. Ziaee V, Yeganeh MH, Moradinejad MH. Peripheral gangrene: A rare presentation of
systemic lupus erythematosus in a child. Am J Case Rep 2013;14:337-40. PMID: PM:24009812
77. Maeda K, Nishi H, Sakaguchi T, Miyagawa S, Ueno T, Kuratani T ,et al. Coronary Artery
Bypass Grafting in a Patient Initially Presenting with Systemic Lupus Erythematosus. Ann
Thorac Cardiovasc Surg 2013; PMID: PM:23995344
78. Ling SY, Huizinga RB, Mayo PR, Frietag DG, Aspeslet LJ, Foster RT. Pharmacokinetics of
voclosporin in renal impairment and hepatic impairment. J Clin Pharmacol 2013; PMID:
PM:23996158

79. Lamagna C, Scapini P, van Ziffle JA, DeFranco AL, Lowell CA. Hyperactivated MyD88
signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity
and inflammation. Proc Natl Acad Sci U S A 2013;110:E3311-E3320. PMID: PM:23940344
80. Kazzaz NM, El-Rifai R. Unusual aetiology of isolated lower motor neuron facial palsy:
systemic lupus erythematosus presenting with cranial nerve palsy and nephritis. BMJ Case Rep
2013;2013:200378. PMID: PM:23978499
81. Naviaux RK. Metabolic features of the cell danger response. Mitochondrion 2013; PMID:
PM:23981537
82. Pagni F, Galimberti S, Goffredo P, Basciu M, Malachina S, Pilla D ,et al. The value of repeat
biopsy in the management of lupus nephritis: an international multicentre study in a large cohort
of patients. Nephrol Dial Transplant 2013; PMID: PM:23975838
83. Tamura K, Uchio-Yamada K, Manabe N, Noto T, Hirota R, Unami A ,et al. Gene Expression
Analysis Detected a Low Expression Level of C1s Gene in ICR-Derived Glomerulonephritis
(ICGN) Mice. Nephron Exp Nephrol 2013;123:34-45. PMID: PM:23989031
84. Caster DJ, Korte EA, Nanda SK, McLeish KR, Oliver RK, G'sell RT ,et al. ABIN1
Dysfunction as a Genetic Basis for Lupus Nephritis. J Am Soc Nephrol 2013; PMID:
PM:23970121
85. Wu JY, Yeh KW, Huang JL. Early predictors of outcomes in pediatric lupus nephritis: Focus
on proliferative lesions. Semin Arthritis Rheum 2013; PMID: PM:23972330
86. Lee PY, Yeh KW, Yao TC, Lee WI, Lin YJ, Huang JL. The outcome of patients with renal
involvement in pediatric-onset systemic lupus erythematosus - a 20-year experience in Asia.
Lupus 2013; PMID: PM:23966304
87. Liu Z, Bethunaickan R, Sahu R, Brenner M, Laragione T, Gulko PS ,et al. The multiple
chemokine-binding Bovine Herpesvirus 1 Glycoprotein G (BHV1gG) inhibits
polymorphonuclear cell but not monocyte migration into inflammatory sites. Mol Med 2013;
PMID: PM:23979709
88. Wang L, Zhang FC, Chen H, Zhang X, Xu D, Li YZ ,et al. Connective tissue diseases in
primary biliary cirrhosis: a population-based cohort study. World J Gastroenterol 2013;19:51317. PMID: PM:23964148
89. Lee SY, Lee SW, Chung WT. Severe inflammation may be caused by hyperferritinemia of
pseudo-pseudo Meigs' syndrome in lupus patients: two cases reports and a literature review. Clin
Rheumatol 2013; PMID: PM:23959446
90. Lee CJ, Suh KS, Kim KH, Chang YK, Na KR, Lee KW. The Clinicopathologic Significance
of Endothelial Tubuloreticular Inclusions in Glomerular Diseases. Ultrastruct Pathol 2013;
PMID: PM:23957425

91. Jiang H, An X, Li Y, Sun Y, Shen G, Tu Y ,et al. Clinical features and prognostic factors of
thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature
review of 105 cases from 1999 to 2011. Clin Rheumatol 2013; PMID: PM:23954922
92. Bozzolo EP, Ramirez GA, Bonavida G, Lanzani C, Scotti R, Dell'antonio G ,et al. Efficacy
and toxicity of treatments for nephritis in a series of consecutive lupus patients. Autoimmunity
2013; PMID: PM:23944610
93. Leffler J, Gullstrand B, Jonsen A, Nilsson JA, Martin M, Blom AM ,et al. Degradation of
neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus
erythematosus. Arthritis Res Ther 2013;15:R84. PMID: PM:23945056
94. Golder V, Connelly K, Staples M, Morand E, Hoi A. Association of Asian ethnicity with
disease activity in SLE: an observational study from the Monash Lupus Clinic. Lupus 2013;
PMID: PM:23942610
95. Su G, Luan Z, Wu F, Wang X, Tang X, Wu N ,et al. Long-term follow-up of autologous
stem cell transplantation for severe paediatric systemic lupus erythematosus. Clin Rheumatol
2013; PMID: PM:23925552
96. Pamuk O, Akbay F, Donmez S, Yilmaz N, Calayir G, Yavuz S. The clinical manifestations
and survival of systemic lupus erythematosus patients in Turkey: report from two centers. Lupus
2013; PMID: PM:23929639
97. Moktefi A, Laude H, Brudy GL, Rozenberg F, Vacher Lavenu MC, Dupin N ,et al.
Trichodysplasia Spinulosa Associated With Lupus. Am J Dermatopathol 2013; PMID:
PM:23928454
98. Ranganathan D, John GT, Healy H, Roberts MJ, Fassett RG, Lipman J ,et al. A Protocol for
the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis
(POEMSLUN): an open-label, randomised controlled trial. BMJ Open 2013;3: PMID:
PM:23929919
99. Soybilgic A, Onel KB, Utset T, Alexander K, Wagner-Weiner L. Safety and immunogenicity
of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26
years. Pediatr Rheumatol Online J 2013;11:29. PMID: PM:23924237
100. Chandran S, Jen KY, Laszik ZG. Recurrent HIV-associated immune complex
glomerulonephritis with lupus-like features after kidney transplantation. Am J Kidney Dis
2013;62:335-8. PMID: PM:23481367
101. Condon MB, Ashby D, Pepper RJ, Cook HT, Levy JB, Griffith M ,et al. Prospective
observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis
with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis 2013;72:1280-6.
PMID: PM:23740227

102. Mok CC, Kwok RC, Yip PS. Effect of renal disease on the standardized mortality ratio and
life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum 2013;65:215460. PMID: PM:23754671
103. Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R ,et al. Baseline
predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the
phase III belimumab trials. Arthritis Rheum 2013;65:2143-53. PMID: PM:23754628
104. Ozcakar ZB, Foster J, Diaz-Horta O, Kasapcopur O, Fan YS, Yalcinkaya F ,et al.
DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum
2013;65:2183-9. PMID: PM:23666765
105. Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS ,et al.
Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 2013;12:1004-15.
PMID: PM:23541482
106. Ekwom PE. Systemic lupus erythematosus (SLE) at the Kenyatta National Hospital. Clin
Rheumatol 2013;32:1215-7. PMID: PM:23456415
107. Pilar F, Lourdes V, Dolores C, Pedro GC, Lucia L, Jesus SM ,et al. Chronic graft-versushost disease of the kidney in patients with allogenic hematopoietic stem cell transplant. Eur J
Haematol 2013;91:129-34. PMID: PM:23710658
108. Rogers N. Imposters of androgenetic alopecia: diagnostic pearls for the hair restoration
surgeon. Facial Plast Surg Clin North Am 2013;21:325-34. PMID: PM:24017974
109. Nisihara RM, Magrini F, Mocelin V, Messias-Reason IJ. Deposition of the lectin pathway
of complement in renal biopsies of lupus nephritis patients. Hum Immunol 2013;74:907-10.
PMID: PM:23639552
110. Flateau C, Asfalou I, Deman AL, Ficko C, Andriamanantena D, Fontan E ,et al. Aortic
thrombus and multiple embolisms during a Mycoplasma pneumoniae infection. Infection
2013;41:867-73. PMID: PM:23696110
111. Franchin G, Son M, Kim SJ, Ben-Zvi I, Zhang J, Diamond B. Anti-DNA antibodies crossreact with C1q. J Autoimmun 2013;44:34-9. PMID: PM:23834843
112. Poisson JL, Low A, Park YA. The treatment of nephrogenic systemic fibrosis with
therapeutic plasma exchange. J Clin Apher 2013;28:317-20. PMID: PM:23426620
113. Pons-Estel GJ, Alarcon GS, Burgos PI, Hachuel L, Boggio G, Wojdyla D ,et al. Mestizos
with systemic lupus erythematosus develop renal disease early while antimalarials retard its
appearance: data from a Latin American cohort. Lupus 2013;22:899-907. PMID: PM:23857989

114. Jasmin R, Sockalingam S, Cheah TE, Goh KJ. Systemic lupus erythematosus in the
multiethnic Malaysian population: disease expression and ethnic differences revisited. Lupus
2013;22:967-71. PMID: PM:23846232
115. Jung SM, Moon SJ, Kwok SK, Ju JH, Park KS, Park SH ,et al. Posterior reversible
encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and
clinical outcome. Lupus 2013;22:885-91. PMID: PM:23846231
116. Vincent FB, Northcott M, Hoi A, Mackay F, Morand EF. Association of serum B cell
activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing
ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
Lupus 2013;22:873-84. PMID: PM:23846230
117. Erten S, Taskaldiran I, Yakut ZI. Are systemic lupus erythematosus patients carrying
MEFV gene less prone to renal involvement? Report of three cases and review of the literature.
Ren Fail 2013;35:1013-6. PMID: PM:23826804
118. Chen Y, Luo R, Xu Y, Cai X, Li W, Tan K ,et al. Generation of systemic lupus
erythematosus-specific induced pluripotent stem cells from urine. Rheumatol Int 2013;33:212734. PMID: PM:23430158
119. Enocsson H, Wettero J, Skogh T, Sjowall C. Soluble urokinase plasminogen activator
receptor levels reflect organ damage in systemic lupus erythematosus. Transl Res 2013; PMID:
PM:23916811
120. Smith JP, Woodward M, Tunstall O, Ramanan A. CAPS: a rare acute abdomen. BMJ Case
Rep 2013;2013: PMID: PM:23904421
121. Caza TN, Fernandez DR, Talaber G, Oaks Z, Haas M, Madaio MP ,et al. HRES-1/Rab4mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for
treatment in SLE. Ann Rheum Dis 2013; PMID: PM:23897774
122. Seredkina N, Van D, V, Berden J, Mortensen E, Rekvig OP. Lupus nephritis: enigmas,
conflicting models and an emerging concept. Mol Med 2013;19:161-9. PMID: PM:23752208
123. Hernandez-Moreno D, de la CR, I, Fidalgo LE, Llaneza L, Soler RF, Perez-Lopez M ,et al.
Noninvasive heavy metal pollution assessment by means of Iberian wolf (Canis lupus signatus)
hair from Galicia (NW Spain): a comparison with invasive samples. Environ Monit Assess 2013;
PMID: PM:23877576
124. Li Y, Raman I, Du Y, Yan M, Min S, Yang J ,et al. Kallikrein transduced mesenchymal
stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation
and oxidative stress. PLoS One 2013;8:e67790. PMID: PM:23935844

125. Yeo SC, Chuah KL, Lee HY, Liew A. An unusual case of glomerulonephritis in a patient
with non-Hodgkin mucosal associated lymphoid tissue (MALT) B-cell lymphoma. BMC
Nephrol 2013;14:158. PMID: PM:23876025
126. Mok CC, Yap DY, Navarra SV, Liu ZH, Zhao MH, Lu L ,et al. Overview of Lupus
Nephritis Management Guidelines and Perspective from Asia. Nephrology (Carlton ) 2013;
PMID: PM:23876069
127. Subramanian SR, Akram R, Velayati A, Chadow H. New development of cardiac
tamponade on underlying effusive-constrictive pericarditis: an uncommon initial presentation of
scleroderma. BMJ Case Rep 2013;2013: PMID: PM:23853085
128. Patschan S, Patschan D, Potulski M, Henze E, Scholze J, Muller GA. Endothelial progenitor
cells in systemic lupus erythematosus. J Nephrol 2013;0. PMID: PM:24052468
129. Nived O, Hallengren C, Alm P, Jonsen A, Sturfelt G, Bengtsson A. An observational study
of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a
defined area of Southern Sweden: the clinical utility of the ACR renal response criteria and
predictors for renal outcome. Scand J Rheumatol 2013; PMID: PM:23829689
130. Jang SY, Dooley MA, Joy MS. Impact of severe hypothyroidism on cyclophosphamide
disposition and routes of metabolism and transport in a patient with treatment-resistant lupus
nephritis. Ann Pharmacother 2013;47:e35. PMID: PM:23737517
131. Mardanpour K, Rahbar M. Histopathologic patterns of adult renal disease in Kermanshah,
Iran: A 6-year review of two referral centers. Caspian J Intern Med 2013;4:717-21. PMID:
PM:24009967
132. Zhang H, Sun Y, Hu R, Luo W, Mao X, Zhao Z ,et al. The regulation of the UCH-L1 gene
by transcription factor NF-kappaB in podocytes. Cell Signal 2013;25:1574-85. PMID:
PM:23567262
133. Choi IA, Park JK, Lee EY, Song YW, Lee EB. Random spot urine protein to creatinine
ratio is a reliable measure of proteinuria in lupus nephritis in Koreans. Clin Exp Rheumatol
2013;31:584-8. PMID: PM:23711154
134. Lenert P, Icardi M, Dahmoush L. ANA (+) ANCA (+) systemic vasculitis associated with
the use of minocycline: case-based review. Clin Rheumatol 2013;32:1099-106. PMID:
PM:23604593
135. Abed T, Ahmed J, O'Shea N, Payne S, Watters GW. Primary laryngeal actinomycosis in an
immunosuppressed woman: a case report. Ear Nose Throat J 2013;92:301-3. PMID:
PM:23904305
136. Hershko AY, Scheiman-Elazari A, Aamar S, Naparstek Y. Extracorporeal
immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus

erythematosus: a feasibility evaluation study. Immunol Res 2013;56:376-81. PMID:

PM:23584986
137. Merola JF, Prystowsky SD, Iversen C, Gomez-Puerta JA, Norton T, Tsao P ,et al.
Association of discoid lupus erythematosus with other clinical manifestations among patients
with systemic lupus erythematosus. J Am Acad Dermatol 2013;69:19-24. PMID: PM:23541758
138. Chauhan SK, Singh VV, Rai R, Rai M, Rai G. Distinct autoantibody profiles in systemic
lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J
Clin Immunol 2013;33:954-64. PMID: PM:23564191
139. Zhang W, Cai Y, Xu W, Yin Z, Gao X, Xiong S. AIM2 facilitates the apoptotic DNAinduced systemic lupus erythematosus via arbitrating macrophage functional maturation. J Clin
Immunol 2013;33:925-37. PMID: PM:23479181
140. Struemper H, Chen C, Cai W. Population pharmacokinetics of belimumab following
intravenous administration in patients with systemic lupus erythematosus. J Clin Pharmacol
2013;53:711-20. PMID: PM:23681782
141. Makino Y, Yamaza H, Akiyama K, Ma L, Hoshino Y, Nonaka K ,et al. Immune therapeutic
potential of stem cells from human supernumerary teeth. J Dent Res 2013;92:609-15. PMID:
PM:23697344
142. Yin XL, Zou MS, Zhang Y, Wang J, Liu TL, Tang JH ,et al. Twenty-three-year review of
disease patterns from renal biopsies: an experience from a pediatric renal center. J Nephrol
2013;26:699-707. PMID: PM:23661591
143. Leiss H, Niederreiter B, Bandur T, Schwarzecker B, Bluml S, Steiner G ,et al. Pristaneinduced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ
and joint inflammation. Lupus 2013;22:778-92. PMID: PM:23817510
144. Moroni G, Quaglini S, Gallelli B, Banfi G, Messa P, Ponticelli C. Progressive improvement
of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis
(LN) followed for 20 years. Lupus 2013;22:810-8. PMID: PM:23764764
145. Stojan G, Fang H, Magder L, Petri M. Erythrocyte sedimentation rate is a predictor of renal
and overall SLE disease activity. Lupus 2013;22:827-34. PMID: PM:23761098
146. Rangel ML, Alghamdi I, Contreras G, Harrington T, Thomas DB, Barisoni L ,et al.
Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic
manifestations. Lupus 2013;22:855-64. PMID: PM:23722230
147. Akhter S, Kamal M. Histomorphological Patterns of Lupus Nephritis with Evaluation of
WHO 1982 and ISN/RPS 2003 Classifications. Mymensingh Med J 2013;22:557-66. PMID:
PM:23982549

148. McCarthy EM, Lee RZ, Ni GJ, Smith S, Cunnane G, Doran MF ,et al. Elevated B
lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus
erythematosus cohort. Rheumatology (Oxford) 2013;52:1279-84. PMID: PM:23479724
149. Li Q, Lin X, Wu Z, He L, Wang W, Cao Q ,et al. Immuno-histochemistry analysis of
Helicobacter pylori antigen in renal biopsy specimens from patients with glomerulonephritis.
Saudi J Kidney Dis Transpl 2013;24:751-8. PMID: PM:23816725
150. Fatma LB, El AZ, Lamia R, Aich DB, Madiha K, Wided S ,et al. Alveolar hemorrhage and
kidney disease: characteristics and therapy. Saudi J Kidney Dis Transpl 2013;24:743-50. PMID:
PM:23816724
151. Radic M, Marion TN. Neutrophil extracellular chromatin traps connect innate immune
response to autoimmunity. Semin Immunopathol 2013;35:465-80. PMID: PM:23595413
152. Dag E, Gokce B, Kocak M. Sneddon's syndrome presenting with neuropathic pain.
Skinmed 2013;11:251-2. PMID: PM:24053013
153. Alonso MD, Martinez-Vazquez F, Riancho-Zarrabeitia L, Diaz de TT, Miranda-Filloy JA,
Blanco R ,et al. Sex differences in patients with systemic lupus erythematosus from Northwest
Spain. Rheumatol Int 2013; PMID: PM:23812032
154. Nee R, Jindal RM, Little D, Ramsey-Goldman R, Agodoa L, Hurst FP ,et al. Racial
differences and income disparities are associated with poor outcomes in kidney transplant
recipients with lupus nephritis. Transplantation 2013;95:1471-8. PMID: PM:23680929
155. Ramaiah SK, Gunthner R, Lech M, Anders HJ. Toll-like receptor and accessory molecule
mRNA expression in humans and mice as well as in murine autoimmunity, transient
inflammation, and progressive fibrosis. Int J Mol Sci 2013;14:13213-30. PMID: PM:23803655
156. Zhang M, Xing CY, Liu J. Study of the efficacy of mizoribine in lupus nephritis in Chinese
patients. Rheumatol Int 2013; PMID: PM:23797779
157. Sutton EJ, Davidson JE, Bruce IN. The Systemic Lupus International Collaborating Clinics
(SLICC) damage index: A systematic literature review. Semin Arthritis Rheum 2013; PMID:
PM:23786872
158. Scheinfeld N. Diseases associated with hidranitis suppurativa: part 2 of a series on
hidradenitis. Dermatol Online J 2013;19:18558. PMID: PM:24011308
159. Ripoll E, Merino A, Goma M, Aran JM, Bolanos N, de RL ,et al. CD40 gene silencing
reduces the progression of experimental lupus nephritis modulating local milieu and systemic
mechanisms. PLoS One 2013;8:e65068. PMID: PM:23799000

160. Lin JA, Liao CC, Lee YJ, Wu CH, Huang WQ, Chen TL. Adverse outcomes after major
surgery in patients with systemic lupus erythematosus: a nationwide population-based study.
Ann Rheum Dis 2013; PMID: PM:23740232
161. Cossey LN, Rahim F, Larsen CP. Oxalate nephropathy and intravenous vitamin C. Am J
Kidney Dis 2013;61:1032-5. PMID: PM:23548555
162. Wofsy D, Hillson JL, Diamond B. Comparison of alternative primary outcome measures for
use in lupus nephritis clinical trials. Arthritis Rheum 2013;65:1586-91. PMID: PM:23529285
163. Isgro J, Gupta S, Jacek E, Pavri T, Duculan R, Kim M ,et al. Enhanced rho-associated
protein kinase activation in patients with systemic lupus erythematosus. Arthritis Rheum
2013;65:1592-602. PMID: PM:23508371
164. Zouali M, Uy EA. Belimumab therapy in systemic lupus erythematosus. BioDrugs
2013;27:225-35. PMID: PM:23568179
165. Horak P, Smrzova A, Krejci K, Tichy T, Zadrazil J, Skacelova M. Renal manifestations of
rheumatic diseases. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
2013;157:98-104. PMID: PM:23752767
166. Zhao C, Zhao J, Huang Y, Wang Z, Wang H, Zhang H ,et al. New-onset systemic lupus
erythematosus during pregnancy. Clin Rheumatol 2013;32:815-22. PMID: PM:23358829
167. Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F. The BAFF/APRIL
system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor
Rev 2013;24:203-15. PMID: PM:23684423
168. Graboyes EM, Allen CT, Chernock RD, Diaz JA. Oral hairy leukoplakia in an HIVnegative patient. Ear Nose Throat J 2013;92:E12. PMID: PM:23780596
169. Tonnesmann E, Kandolf R, Lewalter T. Chloroquine cardiomyopathy - a review of the
literature. Immunopharmacol Immunotoxicol 2013;35:434-42. PMID: PM:23635029
170. Ezzat MH, El-Gammasy TM, Shaheen KY, El-Mezdawi RA, Youssef MS. Up regulation of
serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus
erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and
neutropenia. Int J Rheum Dis 2013;16:310-8. PMID: PM:23981753
171. Zhou H, Hasni SA, Perez P, Tandon M, Jang SI, Zheng C ,et al. miR-150 promotes renal
fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol 2013;24:1073-87.
PMID: PM:23723424
172. Kohut SA, Williams TS, Jayanthikumar J, Landolt-Marticorena C, Lefebvre A, Silverman E
,et al. Depressive symptoms are prevalent in childhood-onset systemic lupus erythematosus
(cSLE). Lupus 2013;22:712-20. PMID: PM:23704369

173. Borba EF, Araujo DB, Bonfa E, Shinjo SK. Clinical and immunological features of 888
Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations.
Lupus 2013;22:744-9. PMID: PM:23687065
174. Kittanamongkolchai W, Rukrung C, Supasiri T, Lertjirachai I, Somparn P, Chariyavilaskul
P ,et al. Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely
active lupus nephritis. Lupus 2013;22:727-32. PMID: PM:23651860
175. Ruggiero B, Vivarelli M, Gianviti A, Benetti E, Peruzzi L, Barbano G ,et al. Lupus nephritis
in children and adolescents: results of the Italian Collaborative Study. Nephrol Dial Transplant
2013;28:1487-96. PMID: PM:23345627
176. Trad B, Ben HH, Khalifa M, Idriss N, Slama F, Bahri F ,et al. Anti-C1q antibodies and
systemic lupus erythematosus in the Tunisian population. Pathol Biol (Paris) 2013;61:113-6.
PMID: PM:23399411
177. . Belimumab. No tangible efficacy but a risk of immunosuppression. Prescrire Int
2013;22:149. PMID: PM:23866349
178. Fischer-Betz R, Specker C, Brinks R, Aringer M, Schneider M. Low risk of renal flares and
negative outcomes in women with lupus nephritis conceiving after switching from
mycophenolate mofetil to azathioprine. Rheumatology (Oxford) 2013;52:1070-6. PMID:
PM:23382355
179. Dhillon PK, Adams MJ. Thrombosis in systemic lupus erythematosus: role of impaired
fibrinolysis. Semin Thromb Hemost 2013;39:434-40. PMID: PM:23504607
180. Hiramatsu R, Hoshino J, Suwabe T, Sumida K, Hasegawa E, Yamanouchi M ,et al.
Membranoproliferative glomerulonephritis and circulating cryoglobulins. Clin Exp Nephrol
2013; PMID: PM:23722669
181. Gilkeson GS, Mashmoushi AK, Ruiz P, Caza TN, Perl A, Oates JC. Endothelial nitric oxide
synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and
MCP1 production in murine lupus nephritis. PLoS One 2013;8:e64650. PMID: PM:23741359
182. Padilla-Fernandez B, Garcia-Casado D, Martin-Izquierdo M, Manzano-Rodriguez C,
Garcia-Garcia J, Lorenzo-Gomez MF. Bilateral renal infarction in a lupus patient: an unusual
pathology. Clin Med Insights Case Rep 2013;6:87-91. PMID: PM:23761987
183. Lai CC, Chen WS, Chang YS, Wang SH, Huang CJ, Guo WY ,et al. Clinical Features and
Outcomes of Posterior Reversible Encephalopathy Syndrome in Patients with Systemic Lupus
Erythematosus. Arthritis Care Res (Hoboken ) 2013; PMID: PM:23687067
184. Parent JJ, Bendaly EA, Hurwitz RA. Abdominal Coarctation and Associated Comorbidities
in Children. Congenit Heart Dis 2013; PMID: PM:23663451

185. Zhang W, Zhou Q, Xu W, Cai Y, Yin Z, Gao X ,et al. DNA-dependent activator of
interferon-regulatory factors (DAI) promotes lupus nephritis by activating the calcium pathway.
J Biol Chem 2013;288:13534-50. PMID: PM:23553627
186. Abrisham SM, Hajiesmaeili MR, Soleimani H, Pahlavanhosseini H. Efficacy of core
decompression of femoral head to treat avascular necrosis in intravenous drug users. Acta Med
Iran 2013;51:250-3. PMID: PM:23690105
187. Walsh M, Solomons N, Lisk L, Jayne DR. Mycophenolate mofetil or intravenous
cyclophosphamide for lupus nephritis with poor kidney function: a subgroup analysis of the
Aspreva Lupus Management Study. Am J Kidney Dis 2013;61:710-5. PMID: PM:23375819
188. Wallbach M, Grone HJ, Kitze B, Muller GA, Koziolek MJ. Nephrotic syndrome in a
multiple sclerosis patient receiving long-term interferon beta therapy. Am J Kidney Dis
2013;61:786-9. PMID: PM:23375818
189. Newman K, Owlia MB, El-Hemaidi I, Akhtari M. Management of immune cytopenias in
patients with systemic lupus erythematosus - Old and new. Autoimmun Rev 2013;12:784-91.
PMID: PM:23462431
190. Sjowall C, Olin AI, Skogh T, Wettero J, Morgelin M, Nived O ,et al. C-reactive protein,
immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus
nephritis. Autoimmunity 2013;46:205-14. PMID: PM:23331132
191. Kanapathippillai P, Hedberg A, Fenton CG, Fenton KA. Nucleosomes contribute to
increase mesangial cell chemokine expression during the development of lupus nephritis.
Cytokine 2013;62:244-52. PMID: PM:23561928
192. Paziana K, Del MM, Cardonick E, Moritz M, Keller M, Smith B ,et al. Ciclosporin use
during pregnancy. Drug Saf 2013;36:279-94. PMID: PM:23516008
193. Mok CC. Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin
Immunol 2013;9:453-63. PMID: PM:23634739
194. Golay V, Trivedi M, Abraham A, Roychowdhary A, Pandey R. The spectrum of glomerular
diseases in a single center: A clinicopathological correlation. Indian J Nephrol 2013;23:168-75.
PMID: PM:23814413
195. Dalkilic E, Filiz G, Yavuz M, Dilek K, Ersoy A, Yurtkuran M ,et al. Ki-67 proliferation
index in renal biopsy samples of patients with systemic lupus erythematosus and its correlation
with clinical findings. Iran J Kidney Dis 2013;7:198-203. PMID: PM:23689151
196. Gladman DD, Ibanez D, Ruiz I, Urowitz MB. Recommendations for frequency of visits to
monitor systemic lupus erythematosus in asymptomatic patients: data from an observational
cohort study. J Rheumatol 2013;40:630-3. PMID: PM:23457385

197. Davies RJ, Sangle SR, Jordan NP, Aslam L, Lewis MJ, Wedgwood R ,et al. Rituximab in
the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus
nephritis. Lupus 2013;22:574-82. PMID: PM:23632989
198. Abujam B, Cheekatla S, Aggarwal A. Urinary CXCL-10/IP-10 and MCP-1 as markers to
assess activity of lupus nephritis. Lupus 2013;22:614-23. PMID: PM:23629827
199. Vachvanichsanong P, McNeil E. Pediatric lupus nephritis: more options, more chances?
Lupus 2013;22:545-53. PMID: PM:23629826
200. Caneparo V, Cena T, De AM, Dell'oste V, Stratta P, Quaglia M ,et al. Anti-IFI16 antibodies
and their relation to disease characteristics in systemic lupus erythematosus. Lupus 2013;22:60713. PMID: PM:23612796
201. Wang R, Xu Y, Lv R, Chen J. Systemic lupus erythematosus associated with Moyamoya
syndrome: a case report and literature review. Lupus 2013;22:629-33. PMID: PM:23574743
202. Cheng CC, Lee YF, Lan JL, Wu MJ, Hsieh TY, Lin NN ,et al. Mycophenolate mofetil
alleviates lupus nephritis through urokinase receptor signaling in a mice model. Lupus
2013;22:554-61. PMID: PM:23478030
203. Shen HN, Yang HH, Lu CL. Temporal trends in characteristics and outcome of intensive
care unit patients with systemic lupus erythematosus in Taiwan: a national population-based
study. Lupus 2013;22:644-52. PMID: PM:23396568
204. Eggers AE. An explanation of how migraine headaches can trigger relapse in systemic
lupus erythematosus. Med Hypotheses 2013;80:553-5. PMID: PM:23395300
205. Wu T, Du Y, Han J, Singh S, Xie C, Guo Y ,et al. Urinary angiostatin--a novel putative
marker of renal pathology chronicity in lupus nephritis. Mol Cell Proteomics 2013;12:1170-9.
PMID: PM:23345539
206. Al RD. The spectrum of glomerular diseases on renal biopsy: data from a single tertiary
center in oman. Oman Med J 2013;28:213-5. PMID: PM:23772291
207. Corona E, Chen R, Sikora M, Morgan AA, Patel CJ, Ramesh A ,et al. Analysis of the
genetic basis of disease in the context of worldwide human relationships and migration. PLoS
Genet 2013;9:e1003447. PMID: PM:23717210
208. Jonsdottir T, Zickert A, Sundelin B, Henriksson EW, van Vollenhoven RF, Gunnarsson I.
Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and
histopathological response. Rheumatology (Oxford) 2013;52:847-55. PMID: PM:23287364
209. Vellanki VS, Parvathina S, Gondi S, Yadla M, Chenu KK, Vishnubhotla S. Post-partum
bilateral renal cortical necrosis in antiphospholipid syndrome and systemic lupus erythematosus.
Saudi J Kidney Dis Transpl 2013;24:549-52. PMID: PM:23640629

210. Furmanczyk-Zawiska A, Baczkowska T, Sadowska A, Szmidt J, Chmura A, Durlik M.

Antiphospholipid antibodies in renal allograft recipients. Transplant Proc 2013;45:1655-60.
PMID: PM:23726642
211. Ingsathit A, Kantachuvesiri S, Rattanasiri S, Avihingsanon Y, Premasathian N, Pongskul C
,et al. Long-term outcome of kidney retransplantation in comparison with first kidney
transplantation: a report from the Thai Transplantation Registry. Transplant Proc 2013;45:142730. PMID: PM:23726588
212. Lim CC, Goh A. A positive anti-nuclear antibody result does not contraindicate living
kidney donation. Transplant Proc 2013;45:1339-42. PMID: PM:23726567
213. Stehle T, Joly D, Vanhille P, Boffa JJ, Remy P, Mesnard L ,et al. Clinicopathological study
of glomerular diseases associated with sarcoidosis : A multicenter study. Orphanet J Rare Dis
2013;8:65. PMID: PM:23631446
214. Zhang J, Zhang Y, Zhang L, Yang J, Ying D, Zeng S ,et al. Epistatic Interaction between
Genetic Variants in Susceptibility Gene ETS1 Correlates with IL-17 Levels in SLE Patients. Ann
Hum Genet 2013; PMID: PM:23614478
215. Pego-Reigosa JM, Cobo-Ibanez T, Calvo-Alen J, Loza-Santamaria E, Rahman A, MunozFernandez S ,et al. Efficacy and safety of non-biologic immunusuppresants in the treatment of
non-renal systemic lupus erythematosus: A systematic review. Arthritis Care Res (Hoboken )
2013; PMID: PM:23609987
216. Ma H, Zhang X, Zhang X, Yang D, Meng L, Zhang Y ,et al. The effect of esculentoside A
on lupus nephritis-prone BXSB mice. Arch Med Sci 2013;9:354-60. PMID: PM:23671449
217. Fajardo-Hermosillo LD, Lopez-Lopez L, Nadal A, Vila LM. Multifocal osteonecrosis in
systemic lupus erythematosus: case report and review of the literature. BMJ Case Rep
2013;2013: PMID: PM:23595183
218. Nickerson KM, Cullen JL, Kashgarian M, Shlomchik MJ. Exacerbated autoimmunity in the
absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1. J Immunol 2013;190:3889-94.
PMID: PM:23467932
219. Kivity S, Katzav A, Arango MT, Landau-Rabi M, Zafrir Y, Agmon-Levin N ,et al. 16/6idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the
mosaic of central nervous system involvement in lupus. BMC Med 2013;11:90. PMID:
PM:23556432
220. Wang SY, Huo JL, Miao YW, Cheng WM, Zeng YZ. Complementary DNA cloning,
sequence analysis, and tissue transcription profile of a novel U2AF2 gene from the Chinese
Banna mini-pig inbred line. Genet Mol Res 2013;12:925-34. PMID: PM:23613239

221. Harvey PR, Gordon C. B-cell targeted therapies in systemic lupus erythematosus: successes
and challenges. BioDrugs 2013;27:85-95. PMID: PM:23456653
222. Faguer S, Ciroldi M, Mariotte E, Galicier L, Rybojad M, Canet E ,et al. Prognostic
contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill
patients with systemic rheumatic diseases. Eur J Intern Med 2013;24:e40-e44. PMID:
PM:23332934
223. Sui W, Hou X, Che W, Yang M, Dai Y. The applied basic research of systemic lupus
erythematosus based on the biological omics. Genes Immun 2013;14:133-46. PMID:
PM:23446742
224. Xie C, Du Y, Kumar K, Li L, Han J, Liu K ,et al. Lupus-prone strains vary in susceptibility
to antibody-mediated end organ disease. Genes Immun 2013;14:170-8. PMID: PM:23392277
225. Zhu P, Xie L, Ding HS, Gong Q, Yang J, Yang L. High mobility group box 1 and kidney
diseases (Review). Int J Mol Med 2013;31:763-8. PMID: PM:23440289
226. Park JH, Kim SB, Shin HS, Jung GH, Jung YS, Rim H. Spontaneous and serial rupture of
both Achilles tendons associated with secondary hyperparathyroidism in a patient receiving
long-term hemodialysis. Int Urol Nephrol 2013;45:587-90. PMID: PM:22241073
227. Larsen CP, Beggs ML, Saeed M, Walker PD. Apolipoprotein L1 risk variants associate with
systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol
2013;24:722-5. PMID: PM:23520206
228. Kansara B, Singh A, Karlekar A, Mishra YK. Aortic valve replacement in a patient with
systemic lupus erythematosus. J Anaesthesiol Clin Pharmacol 2013;29:248-51. PMID:
PM:23878452
229. Singh N, Birkenbach M, Caza T, Perl A, Cohen PL. Tuberous sclerosis and fulminant lupus
in a young woman. J Clin Rheumatol 2013;19:134-7. PMID: PM:23519178
230. Savino MT, Ulivieri C, Emmi G, Prisco D, De FG, Ortensi B ,et al. The Shc family protein
adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. J Leukoc Biol
2013;93:549-59. PMID: PM:23345394
231. Song G, Hu C, Zhu H, Wang L, Zhang F, Li Y ,et al. New centromere autoantigens
identified in systemic sclerosis using centromere protein microarrays. J Rheumatol 2013;40:4618. PMID: PM:23418382
232. Wu LH, Yu F, Tan Y, Qu Z, Chen MH, Wang SX ,et al. Inclusion of renal vascular lesions
in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions.
Kidney Int 2013;83:715-23. PMID: PM:23302713

233. Tomov S, Lazarchick J, Self SE, Bruner ET, Budisavljevic MN. Kidney-limited thrombotic
microangiopathy in patients with SLE treated with romiplostim. Lupus 2013;22:504-9. PMID:
PM:23554039
234. Hammad A, Mosaad Y, Elhanbly S, Youssef H, El RA, Elhusseini F ,et al. Urinary
neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children.
Lupus 2013;22:486-91. PMID: PM:23554037
235. Zhao Y, Wen G, Qiao Z, Xu H, Sun Q, Huang H ,et al. Effects of tetra-arsenic tetra-sulfide
on BXSB lupus-prone mice: a pilot study. Lupus 2013;22:469-76. PMID: PM:23554035
236. Shaharir SS, Remli R, Marwan AA, Said MS, Kong NC. Posterior reversible
encephalopathy syndrome in systemic lupus erythematosus: pooled analysis of the literature
reviews and report of six new cases. Lupus 2013;22:492-6. PMID: PM:23435619
237. Desai N, Cimbaluk D, Lewis EJ, Whittier WL. Proteinuria in membranous lupus nephritis:
the pathology is in the podocyte. Lupus 2013;22:461-8. PMID: PM:23428848
238. Moon SJ, Park HS, Kwok SK, Ju J, Choi BS, Park KS ,et al. Predictors of renal relapse in
Korean patients with lupus nephritis who achieved remission six months following induction
therapy. Lupus 2013;22:527-37. PMID: PM:23423249
239. Van Stralen KJ, Verrina E, Belingheri M, Dudley J, Dusek J, Grenda R ,et al. Impact of
graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric
population. Nephrol Dial Transplant 2013;28:1031-8. PMID: PM:23300261
240. Park MS. Diffuse alveolar hemorrhage. Tuberc Respir Dis (Seoul ) 2013;74:151-62. PMID:
PM:23678356
241. Khubchandani SR, Bichle LS. Hydroxychloroquine-induced phospholipidosis in a case of
SLE: the wolf in zebra clothing. Ultrastruct Pathol 2013;37:146-50. PMID: PM:23573895
242. Singh RR, Yang JQ, Kim PJ, Halder RC. Germline deletion of beta2 microglobulin or
CD1d reduces anti-phospholipid antibody, but increases autoantibodies against non-phospholipid
antigens in the NZB/W F1 model of lupus. Arthritis Res Ther 2013;15:R47. PMID:
PM:23531237
243. Teichmann LL, Schenten D, Medzhitov R, Kashgarian M, Shlomchik MJ. Signals via the
adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune
activation and tissue damage in lupus. Immunity 2013;38:528-40. PMID: PM:23499488
244. Tan Y, Song D, Wu LH, Yu F, Zhao MH. Serum levels and renal deposition of C1q
complement component and its antibodies reflect disease activity of lupus nephritis. BMC
Nephrol 2013;14:63. PMID: PM:23510032

245. Cook HT. Complement and kidney disease. Curr Opin Nephrol Hypertens 2013; PMID:
PM:23508058
246. Sun X, Wiedeman A, Agrawal N, Teal TH, Tanaka L, Hudkins KL ,et al. Increased
ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice. J
Immunol 2013;190:2536-43. PMID: PM:23382559
247. Enghard P, Rieder C, Kopetschke K, Klocke JR, Undeutsch R, Biesen R ,et al. Urinary CD4
T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor
treatment response. Ann Rheum Dis 2013; PMID: PM:23475982
248. Garcia BR, Mas EE, Mas EM, Milla Perseguer MM, Marco BJ, Beltran FJ ,et al. Systemic
lupus erythematosus and thrombotic thrombocytopenia purpura: A refractory case without lupus
activity. Reumatol Clin 2013; PMID: PM:23473755
249. Hanaoka M, Gono T, Kawaguchi Y, Uchida K, Koseki Y, Katsumata Y ,et al. Urinary free
light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis. Rheumatology
(Oxford) 2013; PMID: PM:23463805
250. Anders HJ, Weening JJ. Kidney disease in lupus is not always 'lupus nephritis'. Arthritis
Res Ther 2013;15:108. PMID: PM:23448342
251. Luo X, Zhang L, Li M, Zhang W, Leng X, Zhang F ,et al. The role of miR-125b in T
lymphocytes in the pathogenesis of systemic lupus erythematosus. Clin Exp Rheumatol
2013;31:263-71. PMID: PM:23305626
252. Gao Q, Li Q, Xue Z, Wu P, Yang X. In vitro and in vivo evaluation of a humanized antiAPRIL antibody. Curr Mol Med 2013;13:464-5. PMID: PM:23331019
253. Postal M, Pelicari KO, Sinicato NA, Marini R, Costallat LT, Appenzeller S. Th1/Th2
cytokine profile in childhood-onset systemic lupus erythematosus. Cytokine 2013;61:785-91.
PMID: PM:23332615
254. Sinha A, Puri K, Hari P, Dinda AK, Bagga A. Etiology and outcome of crescentic
glomerulonephritis. Indian Pediatr 2013;50:283-8. PMID: PM:23024099
255. Rolle AS, Zimmermann B, Poon SH. Etanercept-induced Henoch-Schonlein purpura in a
patient with ankylosing spondylitis. J Clin Rheumatol 2013;19:90-3. PMID: PM:23364662
256. Smith LW, Petri M. Lupus enteritis: an uncommon manifestation of systemic lupus
erythematosus. J Clin Rheumatol 2013;19:84-6. PMID: PM:23364660
257. Shovman O, Langevitz P, Gilburd B, Shoenfeld Y. Coincidence of granulomatosis and
polyangiitis with atypical clinical manifestation and antiphospholipid syndrome. Lupus
2013;22:320-3. PMID: PM:23439472

258. Hui M, Garner R, Rees F, Bavakunji R, Daniel P, Varughese S ,et al. Lupus nephritis: a 15year multi-centre experience in the UK. Lupus 2013;22:328-32. PMID: PM:23386411
259. Furst DE, Clarke A, Fernandes AW, Bancroft T, Gajria K, Greth W ,et al. Resource
utilization and direct medical costs in adult systemic lupus erythematosus patients from a
commercially insured population. Lupus 2013;22:268-78. PMID: PM:23340996
260. Alchi B, Jayne D, Labopin M, Demin A, Sergeevicheva V, Alexander T ,et al. Autologous
haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the
European Group for Blood and Marrow Transplantation registry. Lupus 2013;22:245-53. PMID:
PM:23257404
261. Lockhart PB, Blizzard J, Maslow AL, Brennan MT, Sasser H, Carew J. Drug cost
implications for antibiotic prophylaxis for dental procedures. Oral Surg Oral Med Oral Pathol
Oral Radiol 2013;115:345-53. PMID: PM:23265984
262. Sozeri B, Deveci M, Dincel N, Mir S. The early cardiovascular changes in pediatric patients
with systemic lupus erythematosus. Pediatr Nephrol 2013;28:471-6. PMID: PM:23135607
263. Ozcakar ZB, Yalcinkaya F, Altugan FS, Kavaz A, Ensari A, Ekim M.
Hypocomplementemic urticarial vasculitis syndrome in three siblings. Rheumatol Int
2013;33:763-6. PMID: PM:21113808
264. Alwahaibi NY, Alhabsi TA, Alrawahi SA. Pattern of glomerular diseases in Oman: a study
based on light microscopy and immunofluorescence. Saudi J Kidney Dis Transpl 2013;24:38791. PMID: PM:23538373
265. George JN, Charania RS. Evaluation of patients with microangiopathic hemolytic anemia
and thrombocytopenia. Semin Thromb Hemost 2013;39:153-60. PMID: PM:23390027
266. Dolff S, Abdulahad WH, Arends S, van Dijk MC, Limburg PC, Kallenberg CG ,et al.
Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis. Arthritis
Res Ther 2013;15:R36. PMID: PM:23445537
267. Uchida T, Oda T, Watanabe A, Yamamoto K, Katsurada Y, Shimazaki H ,et al. Transition
from endocapillary proliferative glomerulonephritis to membranoproliferative
glomerulonephritis in a patient with a prolonged human parvovirus B19 infection. Clin Nephrol
2013; PMID: PM:23442257
268. Wang IK, Muo CH, Chang YC, Liang CC, Chang CT, Lin SY ,et al. Association between
hypertensive disorders during pregnancy and end-stage renal disease: a population-based study.
CMAJ 2013;185:207-13. PMID: PM:23339156
269. Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA ,et al. New
autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and

the Autoimmune Disease Working Party of the European Group for Blood and Marrow
Transplantation. Blood 2013;121:1059-64. PMID: PM:23247725
270. Erkan D, Vega J, Ramon G, Kozora E, Lockshin MD. A pilot open-label phase II trial of
rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum
2013;65:464-71. PMID: PM:23124321
271. Hussain N, Jaffery G. Distribution of human leukocyte antigen alleles in systemic lupus
erythematosus patients with angiotensin converting enzyme insertion/deletion polymorphism.
Bosn J Basic Med Sci 2013;13:57-62. PMID: PM:23448612
272. Alkhunaizi AM, Dawamneh MF, Banda RW, Daabil RA, Al-Tawfiq JA, Akkad SA ,et al.
Acanthamoeba encephalitis in a patient with systemic lupus treated with rituximab. Diagn
Microbiol Infect Dis 2013;75:192-4. PMID: PM:23265295
273. Topete-Reyes JF, Soto-Vargas J, Moran-Moguel MC, Davalos-Rodriguez IP, ChavezGonzalez EL, Garcia-de la Torre I ,et al. Insertion/deletion polymorphism of the angiotensinconverting enzyme gene in lupus nephritis among Mexicans. Immunopharmacol Immunotoxicol
2013;35:174-80. PMID: PM:23137230
274. Al-Mayouf SM. Systemic lupus erythematosus in Saudi children: long-term outcomes. Int J
Rheum Dis 2013;16:56-60. PMID: PM:23441773
275. Bhat ZY, Zeng X, Hingorani J, Khan S, Mohanty MJ. Fibrillary glomerulonephritis in a
patient with systemic lupus erythematosus: a rare association. Int Urol Nephrol 2013;45:281-4.
PMID: PM:22102086
276. Arogundade FA, Sanusi AA, Akinbodewa AA, Hassan MO, Omotosho BO, Balogun RA ,et
al. Filter membrane-based automated therapeutic plasma exchange: a report of two cases from
Nigeria. J Clin Apher 2013;28:78-83. PMID: PM:23420598
277. Fujita Y, Araki T, Okada Y, Aomori T, Shimizu R, Tomizawa T ,et al. Analysis of
cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood
concentration was markedly elevated after administration of azole antifungal agents. J Clin
Pharm Ther 2013;38:74-6. PMID: PM:22971159
278. Cheunsuchon B, Incharoen P, Chawanasuntorapoj R, Chanchairujira T, Shayakul C.
Glomerular macrophage is an indicator of early treatment response in diffuse proliferative lupus
nephritis. J Med Assoc Thai 2013;96 Suppl 2:S246-S251. PMID: PM:23590049
279. Campos LM, Spadoni MS, Michelin CM, Jesus AA, Carneiro JD, da Silva CA. Thrombotic
thrombocytopenic purpura at presentation of juvenile systemic lupus erythematosus patients. Rev
Bras Reumatol 2013;53:120-6. PMID: PM:23588522

280. Karimifar M, Tahmasebi A, Bonakdar ZS, Purajam S. Correlation of serum prolactin levels
and disease activity in systematic lupus erythematosus. Rheumatol Int 2013;33:511-6. PMID:
PM:22065074
281. Li PH, Wong WH, Lee TL, Lau CS, Chan TM, Leung AM ,et al. Relationship between
autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong
Kong Chinese. Rheumatology (Oxford) 2013;52:337-45. PMID: PM:23038697
282. Lumlertgul D, Suteeka Y, Tumpong S, Bunnachak D, Boonkaew S. Double filtration
plasmapheresis in different diseases in Thailand. Ther Apher Dial 2013;17:99-116. PMID:
PM:23379501
283. Scully P, Leckstroem DC, McGrath A, Chambers J, Goldsmith DJ. Repeated renal
infarction in native and transplanted kidneys due to left ventricular thrombus formation caused
by antiphospholipid antibody syndrome. Int Med Case Rep J 2013;6:7-12. PMID: PM:23750104
284. Martinez-Martinez MU, Mandeville P, Llamazares-Azuara L, Abud-Mendoza C. CKD-EPI
is the most reliable equation to estimate renal function in patients with systemic lupus
erythematosus. Nefrologia 2013;33:99-106. PMID: PM:23364632
285. Fuccio L, Mussetto A, Laterza L, Eusebi LH, Bazzoli F. Diagnosis and management of
gastric antral vascular ectasia. World J Gastrointest Endosc 2013;5:6-13. PMID: PM:23330048
286. Song D, Wu LH, Wang FM, Yang XW, Zhu D, Chen M ,et al. The spectrum of renal
thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 2013;15:R12. PMID:
PM:23320601
287. Kara A, Sari S, Seker A, Ozturk I. Osteotendinous repair of bilateral spontaneous
quadriceps tendon ruptures with the Krackow technique in two patients with chronic renal
failure. Acta Orthop Traumatol Turc 2013;47:68-71. PMID: PM:23549321
288. Thurman JM, Rohrer B. Noninvasive detection of complement activation through radiologic
imaging. Adv Exp Med Biol 2013;734a:271-82. PMID: PM:22990710
289. Abdel-Wahab AF, Fathy O, Al-Harizy R. Negative correlation between fetuin-A and
indices of vascular disease in systemic lupus erythematosus patients with and without lupus
nephritis. Arab J Nephrol Transplant 2013;6:11-20. PMID: PM:23282228
290. Levy DM, Peschken CA, Tucker LB, Chedeville G, Huber AM, Pope JE ,et al. Influence of
ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic
multicenter Canadian cohort. Arthritis Care Res (Hoboken ) 2013;65:152-60. PMID:
PM:22744999
291. Reddy V, Jayne D, Close D, Isenberg D. B-cell depletion in SLE: clinical and trial
experience with rituximab and ocrelizumab and implications for study design. Arthritis Res Ther
2013;15 Suppl 1:S2. PMID: PM:23566295

292. Zhou XJ, Cheng FJ, Qi YY, Zhao MH, Zhang H. A replication study from Chinese supports
association between lupus-risk allele in TNFSF4 and renal disorder. Biomed Res Int
2013;2013:597921. PMID: PM:23936824
293. Master SR, V. An unusual presentation of lupus in a pediatric patient. Case Rep Pediatr
2013;2013:180208. PMID: PM:24066251
294. Schlaf G, Pollok-Kopp B, Schabel E, Altermann W. Artificially Positive Crossmatches Not
Leading to the Refusal of Kidney Donations due to the Usage of Adequate Diagnostic Tools.
Case Rep Transplant 2013;2013:746395. PMID: PM:23662241
295. Paloyo S, Sageshima J, Chen L, Burke GW, III, Ciancio G. Aneurysmectomy with partial
nephrectomy on a living donor renal allograft: a case report. Case Rep Transplant
2013;2013:791413. PMID: PM:23509658
296. Han Y, Zeng F, Tan G, Yang C, Tang H, Luo Y ,et al. Hydrogen sulfide inhibits abnormal
proliferation of lymphocytes via AKT/GSK3beta signal pathway in systemic lupus
erythematosus patients. Cell Physiol Biochem 2013;31:795-804. PMID: PM:23735868
297. Zhou XS, Li J, Wang LH, Wang C, Wu RP, Li RS. Matrix-assisted laser
desorption/ionization time of flight mass spectrometry in the genetic basis of systemic lupus
erythematosus and the complicating kidney injury. Chin Med J (Engl ) 2013;126:2821-5. PMID:
PM:23924449
298. Kow NY, Mak A. Costimulatory pathways: physiology and potential therapeutic
manipulation in systemic lupus erythematosus. Clin Dev Immunol 2013;2013:245928. PMID:
PM:24000287
299. Chafin CB, Reilly CM. MicroRNAs implicated in the immunopathogenesis of lupus
nephritis. Clin Dev Immunol 2013;2013:430239. PMID: PM:23983769
300. Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D ,et al. Low-dose tacrolimus in treating lupus
nephritis refractory to cyclophosphamide: a prospective cohort study. Clin Exp Rheumatol
2013;31:62-8. PMID: PM:22935463
301. Weening JJ, Ronco P, Remuzzi G. Advances in the pathology of glomerular diseases.
Contrib Nephrol 2013;181:12-21. PMID: PM:23689563
302. Mendez-Flores S, Charli-Joseph Y, Saeb-Lima M, Orozco-Topete R, Fernandez SM.
Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus
erythematosus case series and first report on the association with autoimmune hepatitis.
Dermatology 2013;226:1-4. PMID: PM:23467024
303. Zhong LL, Bian ZX, Gu JH, Zhou X, Tian Y, Mao JC ,et al. Chinese Herbal Medicine (Zi
Shen Qing) for Mild-to-Moderate Systematic Lupus Erythematosus: A Pilot Prospective, Single-

Blinded, Randomized Controlled Study. Evid Based Complement Alternat Med

2013;2013:327245. PMID: PM:23737826
304. Pohl D, Benseler S. Systemic inflammatory and autoimmune disorders. Handb Clin Neurol
2013;112:1243-52. PMID: PM:23622335
305. Verhey LH, Banwell BL. Inflammatory, vascular, and infectious myelopathies in children.
Handb Clin Neurol 2013;112:999-1017. PMID: PM:23622308
306. Yong JL, Killingsworth MC, Lai K. Renal biopsy pathology in a cohort of patients from
southwest Sydney with clinically diagnosed systemic lupus erythematosus. Int J Nephrol
Renovasc Dis 2013;6:15-26. PMID: PM:23431084
307. Sun CY, Shen Y, Chen XW, Yan YC, Wu FX, Dai M ,et al. The Characteristics and
Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local
BAFF Expression. Int J Rheumatol 2013;2013:954292. PMID: PM:23843794
308. Kurasawa T, Nagasawa H, Nishi E, Takei H, Okuyama A, Kondo T ,et al. Successful
treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids,
tacrolimus and intravenous cyclophosphamide. Intern Med 2013;52:1125-30. PMID:
PM:23676603
309. Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S ,et al. CastlemanKojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a
constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia,
myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima
(6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop 2013;53:57-61.
PMID: PM:23801135
310. Furst DE, Clarke A, Fernandes AW, Bancroft T, Gajria K, Greth W ,et al. Medical costs
and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an
insured population. J Med Econ 2013;16:500-9. PMID: PM:23363329
311. Merinopoulos I, Vassiliou V, Porter JN, Acton S, Braganza DR. An unusual but reversible
cause of ventricular fibrillation. J R Coll Physicians Edinb 2013;43:119-21. PMID:
PM:23734352
312. Griffin B, Lightstone L. Renoprotective strategies in lupus nephritis: beyond
immunosuppression. Lupus 2013;22:1267-73. PMID: PM:24097999
313. Bentham J, Vyse T. The development of genome-wide association studies and their
application to complex diseases, including lupus. Lupus 2013;22:1205-13. PMID: PM:24097992
314. Picceli V, Skare T, Nisihara R, Kotze L, Messias-Reason I, Utiyama S. Spectrum of
autoantibodies for gastrointestinal autoimmune diseases in systemic lupus erythematosus
patients. Lupus 2013;22:1150-5. PMID: PM:24057059

315. Concannon A, Rudge S, Yan J, Reed P. The incidence, diagnostic clinical manifestations
and severity of juvenile systemic lupus erythematosus in New Zealand Maori and Pacific Island
children: The Starship experience (2000-2010). Lupus 2013;22:1156-61. PMID: PM:24003079
316. Mok C, To C, Yu K, Ho L. Combined low-dose mycophenolate mofetil and tacrolimus for
lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
Lupus 2013;22:1135-41. PMID: PM:23995863
317. Li M, Zhang W, Leng X, Li Z, Ye Z, Li C ,et al. Chinese SLE Treatment and Research
group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus
erythematosus. Lupus 2013;22:1192-9. PMID: PM:23963101
318. Hillebrand J, Moens HB, Mulder A. Changes in Farr radioimmunoassay and EliA
fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE. Lupus 2013;22:116973. PMID: PM:23929638
319. Voss A, Laustrup H, Hjelmborg J, Junker P. Survival in systemic lupus erythematosus,
1995-2010. A prospective study in a Danish community. Lupus 2013;22:1185-91. PMID:
PM:23873432
320. Lionaki S, Vlachopanos G, Georgalis A, Ziakas P, Gakiopoulou H, Petra C ,et al. Lupus
nephritis and non-Hodgkin lymphoma simultaneously diagnosed in a patient on methimazole.
Lupus 2013;22:95-8. PMID: PM:23263868
321. Harward LE, Mitchell K, Pieper C, Copland S, Criscione-Schreiber LG, Clowse ME. The
impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic
disease. Lupus 2013;22:81-6. PMID: PM:23263867
322. Dooley MA, Houssiau F, Aranow C, D'Cruz DP, Askanase A, Roth DA ,et al. Effect of
belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in
patients with SLE. Lupus 2013;22:63-72. PMID: PM:23263865
323. Nishi E, Kameda H, Ogawa H, Nagasawa H, Takei H, Okuyama A ,et al. Efficacy of
weekly mizoribine pulse therapy in refractory lupus nephritis. Mod Rheumatol 2013;23:97-103.
PMID: PM:22526831
324. Villalta D, Bizzaro N, Bassi N, Zen M, Gatto M, Ghirardello A ,et al. Anti-dsDNA antibody
isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify
glomerulonephritis and active disease. PLoS One 2013;8:e71458. PMID: PM:23951169
325. Wen Z, Xu L, Xu W, Yin Z, Gao X, Xiong S. Interleukin-17 expression positively
correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA
antibody production in a lupus model induced by activated lymphocyte derived DNA. PLoS One
2013;8:e58161. PMID: PM:23472149

326. Jovanovic V, Abdul AN, Lim YT, Ng Ai PA, Jin Hui CS, Ho Xin PE ,et al. Lipid anti-lipid
antibody responses correlate with disease activity in systemic lupus erythematosus. PLoS One
2013;8:e55639. PMID: PM:23409013
327. Golay V, Trivedi M, Kurien AA, Sarkar D, Roychowdhary A, Pandey R. Spectrum of
nephrotic syndrome in adults: clinicopathological study from a single center in India. Ren Fail
2013;35:487-91. PMID: PM:23438313
328. Law ST, Ma KM, Li KK. Clinical characteristics of concurrent and sequentially presented
lupus-related protein-losing enteropathy: what are their differences? Rheumatol Int 2013;33:8592. PMID: PM:22218644
329. Caltik A, Demircin G, Bulbul M, Erdogan O, Akyuz SG, Arda N. An unusual case of ANA
negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and fullhouse nephropathy. Rheumatol Int 2013;33:219-22. PMID: PM:20532511
330. Draman CR, Seman MR, Mohd Noor FS, Kelsom WM. Diagnostic yield of kidney biopsies
performed in a suburban, satellite hospital. Saudi J Kidney Dis Transpl 2013;24:178-83. PMID:
PM:23354221
331. Jeganathan J, Kumar S, Khalid M, Maroli C. Pattern of glomerular diseases in a tertiary
care center in South India: a prospective study. Saudi J Kidney Dis Transpl 2013;24:168-71.
PMID: PM:23354219
332. Klamroth R, Orlovic M, Fritsche I, Seibt S, Seibt F, Wegscheider K ,et al. The influence of
thrombophilic risk factors on vascular access survival in chronic dialysis patients in a
retrospective evaluation. Vasa 2013;42:32-9. PMID: PM:23385224
333. Nakatani S, Ishimura E, Mori K, Fukumoto S, Yamano S, Wei M ,et al. Nephronectin
expression in glomeruli of renal biopsy specimens from various kidney diseases: nephronectin is
expressed in the mesangial matrix expansion of diabetic nephropathy. Nephron Clin Pract
2012;122:114-21. PMID: PM:23689482
334. Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K ,et al. Long-term
tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a
prospective study in daily clinical practice. Nephron Clin Pract 2012;121:c165-c173. PMID:
PM:23327881